Exact Mass: 850.2181

Exact Mass Matches: 850.2181

Found 22 metabolites which its exact mass value is equals to given mass value 850.2181, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

8)epicatechin

Epiafzelechin(4beta-

C45H38O17 (850.2109)

2-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

NCGC00380483-01!2-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

C42H42O19 (850.232)

2-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

NCGC00380483-02!2-[4,5-dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

C42H42O19 (850.232)

ent-Fisetinidol-(4beta->8)-catechin-(6->4beta)-ent-fisetinidol

C45H38O17 (850.2109)

Diacetato[(S)-(-)-2,2-bis(diphenylphosphino)-5,5,6,6,7,7,8,8-octahydro-1,1-binaphthy]ruthenium(II)

C48H46O4P2Ru (850.1915)

Diacetato[(R)-(+)-2,2-bis(diphenylphosphino)-5,5,6,6,7,7,8,8-octahydro-1,1-binaphthy]ruthenium(II)

C48H46O4P2Ru (850.1915)

AV-412 Tosylate

C41H44ClFN6O7S2 (850.2385)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents

Chlorhexidine phosphanilate

C34H46Cl2N12O6P2 (850.2515)

C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent D007004 - Hypoglycemic Agents > D001645 - Biguanides

Thymidylyl(3-5)thymidylyl(3-5)thymidine

C30H40N6O19P2 (850.1823)

Succinamide-CoA

C25H41N8O19P3 (850.1701)

2-[4,5-Dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

2-[4,5-Dihydroxy-2-(hydroxymethyl)-10-oxo-9-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-yl]-1,8,10-trihydroxy-6-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]anthracen-9-one

C42H42O19 (850.232)

LPIP3 P-20:1

C29H58O20P4 (850.2472)

4-[5,7-bis(acetyloxy)-3-[5,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-4-oxochromen-8-yl]-4-oxo-2,3-dihydro-1-benzopyran-2-yl]phenyl acetate

C44H34O18 (850.1745)

(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3r)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C45H38O17 (850.2109)

2-(3,4-dihydroxyphenyl)-4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

2-(3,4-dihydroxyphenyl)-4-[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C45H38O17 (850.2109)

15,19-dimethyl-22-oxa-6λ⁶-thia-9-azapentacyclo[12.9.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁰]tricosa-1,3(12),5(10),13,18,20-hexaene-4,6,6,11,23-pentone; 15,19-dimethyl-22-oxa-9λ⁶-thia-6-azapentacyclo[12.9.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁰]tricosa-1,3(12),5(10),13,18,20-hexaene-4,9,9,11,23-pentone

15,19-dimethyl-22-oxa-6λ⁶-thia-9-azapentacyclo[12.9.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁰]tricosa-1,3(12),5(10),13,18,20-hexaene-4,6,6,11,23-pentone; 15,19-dimethyl-22-oxa-9λ⁶-thia-6-azapentacyclo[12.9.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁰]tricosa-1,3(12),5(10),13,18,20-hexaene-4,9,9,11,23-pentone

C44H38N2O12S2 (850.1866)

(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2r,3r,4s)-2-(3,4-dihydroxyphenyl)-4-[(2r,3s)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2h-1-benzopyran-8-yl]-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C45H38O17 (850.2109)

4-[(2r,3s)-5,7-bis(acetyloxy)-3-[5,7-bis(acetyloxy)-2-[3,4-bis(acetyloxy)phenyl]-4-oxochromen-8-yl]-4-oxo-2,3-dihydro-1-benzopyran-2-yl]phenyl acetate

C44H34O18 (850.1745)